Bausch Health Cos Long Term Debt 2012-2026 | BHC
Bausch Health Cos long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
|
Bausch Health Cos Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $20,615 |
| 2024 | $18,942 |
| 2023 | $21,938 |
| 2022 | $20,334 |
| 2021 | $22,654 |
| 2020 | $23,925 |
| 2019 | $24,661 |
| 2018 | $24,077 |
| 2017 | $25,235 |
| 2016 | $29,845 |
| 2015 | $30,265 |
| 2014 | $15,228 |
| 2013 | $17,163 |
| 2012 | $10,535 |
| 2011 | $6,540 |
|
Bausch Health Cos Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2026-06-30 | $19,898 |
| 2026-03-31 | $19,895 |
| 2025-12-31 | $20,615 |
| 2025-09-30 | $20,463 |
| 2025-06-30 | $20,859 |
| 2025-03-31 | $21,228 |
| 2024-12-31 | $18,942 |
| 2024-09-30 | $21,054 |
| 2024-06-30 | $21,208 |
| 2024-03-31 | $21,536 |
| 2023-12-31 | $21,938 |
| 2023-09-30 | $21,894 |
| 2023-06-30 | $20,108 |
| 2023-03-31 | $20,207 |
| 2022-12-31 | $20,334 |
| 2022-09-30 | $20,804 |
| 2022-06-30 | $21,664 |
| 2022-03-31 | $23,168 |
| 2021-12-31 | $22,654 |
| 2021-09-30 | $22,358 |
| 2021-06-30 | $23,439 |
| 2021-03-31 | $23,738 |
| 2020-12-31 | $23,925 |
| 2020-09-30 | $24,343 |
| 2020-06-30 | $24,357 |
| 2019-12-31 | $24,661 |
| 2019-09-30 | $23,466 |
| 2019-06-30 | $24,023 |
| 2019-03-31 | $23,924 |
| 2018-12-31 | $24,077 |
| 2018-09-30 | $24,433 |
| 2018-06-30 | $24,858 |
| 2018-03-31 | $25,266 |
| 2017-12-31 | $25,235 |
| 2017-09-30 | $26,216 |
| 2017-06-30 | $27,648 |
| 2017-03-31 | $28,198 |
| 2016-12-31 | $29,845 |
| 2016-09-30 | $30,386 |
| 2016-06-30 | $30,773 |
| 2016-03-31 | $31,303 |
| 2015-12-31 | $30,265 |
| 2015-09-30 | $30,176 |
| 2015-06-30 | $30,290 |
| 2015-03-31 | $25,898 |
| 2014-12-31 | $15,228 |
| 2014-09-30 | $15,584 |
| 2014-06-30 | $17,059 |
| 2014-03-31 | $17,148 |
| 2013-12-31 | $17,163 |
| 2013-09-30 | $17,044 |
| 2013-06-30 | $10,447 |
| 2013-03-31 | $10,327 |
| 2012-12-31 | $10,535 |
| 2012-09-30 | $7,423 |
| 2012-06-30 | $7,356 |
| 2012-03-31 | $6,851 |
| 2011-12-31 | $6,540 |
| 2011-09-30 | $5,188 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.129B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |